Pond, Gregory R.

Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study

Berthold, D. R., Pond, G. R., Soban, F., de Wit, R., Eisenberger, M., & Tannock, I. F. (2008) · Journal of Clinical Oncology

Prostate Cancer Treatment and ResearchBone health and treatments

Cited by 1,145

Randomized Trial of a Telephone-Based Weight Loss Intervention in Postmenopausal Women With Breast Cancer Receiving Letrozole: The LISA Trial

Goodwin, P. J., Segal, R. J., Vallis, M., Ligibel, J. A., Pond, G. R., Robidoux, A., Blackburn, G. L., Findlay, B., Gralow, J. R., Mukherjee, S., et al. (2014) · Journal of Clinical Oncology

Cancer Risks and FactorsCancer survivorship and care

Cited by 197

The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer

Pond, G. R., Sonpavde, G., de Wit, R., Eisenberger, M. A., Tannock, I. F., & Armstrong, A. J. (2014) · European Urology

Prostate Cancer Treatment and ResearchBone health and treatments

Cited by 193

Association of metformin with breast cancer incidence and mortality in patients with type II diabetes: A grade-assessed systematic review and meta-analysis

Tang, G. H., Satkunam, M., Pond, G. R., Steinberg, G. R., Blandino, G., Schünemann, H. J., & Muti, P. (2018) · Cancer Epidemiology, Biomarkers & Prevention

Metabolism, Diabetes, and CancerCancer Risks and Factors

Cited by 117

Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy

Dhillon, H. M., Tannock, I. F., Pond, G. R., Renton, C., Rourke, S. B., & Vardy, J. L. (2018) · Journal of Cancer Survivorship

Cancer-related cognitive impairment studiesCancer survivorship and care

Cited by 88

A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial

for the FUPII Trial Investigators, Boekhout, A. H., Maunsell, E., Pond, G. R., Julian, J. A., Coyle, D., Levine, M. N., & Grunfeld, E. (2015) · Journal of Cancer Survivorship

Cancer survivorship and carePatient-Provider Communication in Healthcare

Cited by 88

Factors associated with not receiving homecare, end-of-life homecare, or early homecare referral among cancer decedents: A population-based cohort study

Bainbridge, D., Seow, H., Sussman, J., Pond, G., & Barbera, L. (2015) · Health Policy

Palliative Care and End-of-Life IssuesPalliative and Oncologic Care

Cited by 18

Association of immune-related adverse events (irAEs) with clinical benefit in patients with metastatic urothelial carcinoma (mUC) treated with immune-checkpoint inhibitors (ICIs).

Pier Vitale, N., Pond, G. R., Abou Alaiwi, S., Nassar, A., Flippot, R., Choueiri, T. K., Harshman, L. C., & Sonpavde, G. (2019) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments

Cited by 4